You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Preclinical testing of a 3D printed external scaffold device to prevent vein graft failure after coronary bypass graft surgery
SBC: BIOGRAFT, INC. Topic: NHLBISaphenous vein graft (SVG) failure following coronary artery bypass grafting (CABG) is a critical clinical problem, with recent studies revealing that as many as 25% of vein grafts develop stenosis within 12-18 months after surgery, and up to 50% of grafts occlude within 5-10 years. CABG surgery is the gold standard treatment for patients with severe multi-vessel disease, with over 370,000 procedu ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Epigenetic Markers and Sustained Cytoprotection for Stroke Treatment
SBC: ZYMO RESEARCH CORP. Topic: NINDSPROJECT SUMMARY/ABSTRACT Stroke injury occurs over a long duration through pathologic changes leading to long-term neurologic dysfunction. There is an urgent need of therapeutic strategies that can provide safe and efficacious therapeutic effects to the hypoperfused brain with long-lasting endogenous neuroprotection for prevention of long-term neurologic dysfunction. Sufficient evidence has pointe ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
A rapid test for congenital syphilis screening
SBC: MelioLabs Inc. Topic: NICHDPROJECT SUMMARY Since 2014, Congenital Syphilis (CS) cases in the United States, caused by the transplacental transmission of the bacterium Treponema pallidum from mother to child, have increased at an alarming rate. Targeted surveillance studies indicate a rise andgt;185% from 2014 to 2018 alone. Women who acquire syphilis within 4 years of pregnancy will transmit the infection to 80% of their fe ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
AIDen: An AI-empowered detection and diagnosis system for jaw lesions using CBCT
SBC: MS Technologies Corporation Topic: NIDCRDental CBCT is a 3D imaging modality widely adopted to help dentists detect and diagnose jaw lesions. Due to minimum information loss (compared to conventional 2D radiography) and low radiation exposure (compared to conventional CT), it has become the “go-to” radiographic technique in various dental fields. Gaps: Accompanying the clear benefits of dental CBCT is an overwhelming amount of 3D da ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
HBI-002 to Treat Parkinson’s Disease
SBC: Hillhurst Biopharmaceuticals, Inc. Topic: 107PROJECT SUMMARY The goal of the proposed project is to evaluate the potential of HBI-002, a novel oral formulation of carbon monoxide (CO), as a neuroprotective agent in Parkinson’s disease (PD). A growing body of research suggests that low doses of CO - and the heme oxygenase (HO) enzymes that generate endogenous CO - protect against neuronal cell loss in PD, and epidemiologic studies have asso ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Bronchoscopic lung navigation system for accurately excising lung nodules
SBC: Navigation Sciences, Inc. Topic: 102ABSTRACT The long-term goal of this project is to develop and commercialize a navigation system that can accurately determine margins in real-time during surgery for lung cancer. Surgery is currently the standard of care for early stage lung cancer. A critical challenge is to reliably identify small, early-stage tumors and resect them with sufficient margins (distance between the edge of tumor and ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Next generation anti-cancer drugdelivering cement for bone metastasis patients
SBC: CURER INC Topic: 102Abstract Our mission is to develop an innovative anti-cancer drug delivering bone cement for bone metastasis patients, which can be injected into metastasis-caused bone degeneration sites in a minimally invasive manner, to regress cancer, regenerate bone, and stop the pain. Metastasis is the main cause of cancer death. Bone is one of the most frequent cancer metastatic sites. About 350,000 America ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
An automated system to differentiate Kawasaki disease from febrile illness with real life clinical datasets in New York City
SBC: HBI SOLUTIONS INC. Topic: 100ABSTRACT – Kawasaki disease (KD) is the most common cause of acquired heart disease in children. Treatment with intravenous immunoglobulin (IVIG) reduces the incidence of coronary aneurysms and risk of long-term cardiovascular complications. IVIG is recommended to be given within 10 days of illness; however only 4.7% receive the correct diagnosis at the first medical visit. Timely and accurately ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Targeting a non-opioid signaling pathway to reverse opioid-induced respiratory depression
SBC: Olfa Thera, Inc. Topic: NIDAProject Summary/AbstractThe opioid epidemic is a growing public health crisis with dramatic increase in overdose deaths caused by potent opioids like fentanyl. Currently, the standard treatment for opioid-induced respiratory depression is naloxone, a µ-opioid receptor antagonist. However, naloxone is less effective against potent synthetic opioids like fentanyl and induces withdrawal in chronic o ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Shim System for Removing ICD Artifacts from Patient Cardiac MR Images
SBC: MIRTECH INC Topic: NHLBIProject Abstract1.4 million people in the US (2021) have implanted cardioverter-defibrillators (ICDs) of which ~50% will require an MRI scan in their lifetime. All ICDs generate large artifacts in MRI such as signal-voids in cardiac MR (cMR) images, which frequently occur in important pathological (infarcted) regions. Reliable diagnosis of ventricular tachycardia, premature ventricular contraction ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health